5Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: a statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke, 1999,30:2502-2511.
6Johnston SC, Smith WS. Practice variability in management of transient ischemic attacks. Eur Neurol, 1999, 42:105 - 108.
7Intercollegiate Working Party for Stroke. National Clinical Guidelines for Stroke: Update 2002. Sudbury, Suffolk, UK: Lavenham Press Ltd, 2002.
8SIGN guidelines: management of patients with stroke. 1997. Available at http://www.sign.ac.uk. Accessed October 5, 2004.
9Fisher M. Occlusion of the internal carotid artery. Arch Neurol Psychiat, 1951, 65:346 -377.
10Wright IS, Millikan CH, eds. Cerebral Vascular Disease. New York:Grune & Stratton, 1958:81 -97.
6[6]Grundy SM,Clemen JL,Mers CN,et al.Implication of recent clinical trials for the national cholesterol education program adult treatment panel Ⅲ guideline[J].Circulation,2004,110(2):227-230.
7[8]Roivainen M,Kajander MV,Palosuo P,et al.Infections,Inflammation,and the risk of coronary heart disease[J].Circulation,2000,101(3):252-259.
8[9]Downs JR.Clearfield M,Whitney E,et al.Primary prevention of acute coronary events with lovastatin in men and women with average choresterol levels[J].JAMA,1998,279(20):1615-1622.
9[11]Rutishauser J.The role of statins in clinical medicine.LDH-cholesterol lowering and beyond[J].Swiss Med Wkly,2005,136(7):41-49.
10[12]Castilla GL,Del C,Lopez C,et al.Statins in stroke prevention:What an internist should know[J].Eur J Intern Med,2008,19(1):8-14.
